全文获取类型
收费全文 | 1166篇 |
免费 | 91篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 63篇 |
妇产科学 | 2篇 |
基础医学 | 169篇 |
口腔科学 | 7篇 |
临床医学 | 166篇 |
内科学 | 316篇 |
皮肤病学 | 14篇 |
神经病学 | 7篇 |
特种医学 | 25篇 |
外科学 | 78篇 |
综合类 | 82篇 |
预防医学 | 60篇 |
眼科学 | 8篇 |
药学 | 68篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 194篇 |
出版年
2024年 | 4篇 |
2023年 | 22篇 |
2022年 | 47篇 |
2021年 | 56篇 |
2020年 | 46篇 |
2019年 | 51篇 |
2018年 | 54篇 |
2017年 | 44篇 |
2016年 | 36篇 |
2015年 | 46篇 |
2014年 | 88篇 |
2013年 | 117篇 |
2012年 | 72篇 |
2011年 | 66篇 |
2010年 | 61篇 |
2009年 | 46篇 |
2008年 | 59篇 |
2007年 | 54篇 |
2006年 | 37篇 |
2005年 | 37篇 |
2004年 | 37篇 |
2003年 | 23篇 |
2002年 | 26篇 |
2001年 | 15篇 |
2000年 | 13篇 |
1999年 | 9篇 |
1998年 | 7篇 |
1997年 | 11篇 |
1996年 | 14篇 |
1995年 | 4篇 |
1994年 | 11篇 |
1993年 | 4篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 2篇 |
1989年 | 6篇 |
1988年 | 1篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 11篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有1275条查询结果,搜索用时 15 毫秒
121.
122.
Vanhee LM Symoens F Nelis HJ Coenye T 《Diagnostic microbiology and infectious disease》2008,62(1):96-98
Microsatellite typing was used to analyze 41 Aspergillus fumigatus isolates from 9 patients with proven invasive aspergillosis hospitalized in 2 different centers. No strains were shared between patients. For 8 of 9 patients, a single genotype was found for the isolates recovered from all anatomic sites involved. 相似文献
123.
BACKGROUND: Determining the outcome of patients with aspergillosis can be particularly difficult because patients with aspergillosis are at risk for other conditions that mimic this infection. Galactomannan is an Aspergillus-specific antigen released during invasive aspergillosis and is detected by the quantitative serum galactomannan index (GMI) test. METHODS: Using a kappa correlation coefficient test (KCC), the strength of correlation was determined between GMI and survival outcome of aspergillosis among 56 adults with hematologic cancer (90% had myeloma) who underwent serial GMI monitoring until hospital discharge or death. RESULTS: All 56 patients received antineoplastic therapy (myeloablative followed by stem cell transplantation [autologous in 21 patients and allogeneic in 3 patients] or nonmyeloablative therapy [32 patients]). The overall correlation between survival outcome and GMI was excellent (KCC = 0.8609; 95% confidence interval [95% CI], 0.7093-1.000 [P < .0001]) and was comparable among neutropenic and nonneutropenic patients (KCC = 0.8271; 95% CI, 0.6407-1.000 [P < .0001] and KCC = 1.0; 95% CI, 1-1 [P = .0083], respectively). CONCLUSIONS: The survival outcome of patients with aspergillosis strongly correlated with serum GMI. These findings have important implications for patient care and clinical trials of mold-active antifungal agents. 相似文献
124.
125.
126.
William F. Durham PhD Homer R. Wolfe Joseph W. Elliott MS 《Archives of environmental & occupational health》2013,68(6):381-387
Significant amounts of the urinary metabolite p-nitrophenol were detected in the urine of spraymen as long as ten days after last exposure to the organophosphorus insecticide, parathlon. Approximately two days after exposure, excretion was insignificant during late night and early morning hours, but reached higher levels during midday. The height of Immediate postexposure excretory peaks and the delayed midday rises in excretion seemed to vary directly with the temperature. Bathing after exposure was associated with a rapid decrease in p-nitrophenol excretion, Tests considering only one route of exposure at a time Indicated that the dermal route represents a potentially greater source of absorption than the respiratory route for orchard spraymen using liquid parathion formulations under the conditions of this study. However, with equivalent absorbed dosages the respiratory route is the more hazardous. 相似文献
127.
《Veterinary Nursing Journal》2013,28(7):169-173
AbstractA Humboldt penguin chick presented with dyspnoea. Radiographs showed opacities on the lungs and radio-opaque material within the ventriculus. A ventriculotomy was performed to remove the opacities (which were pebbles) and nutritional, medical and supportive nursing care was provided. Despite recovering well, the chick presented dyspnoeic again a few weeks later. With diagnostic testing indicative of chronic aspergillosis, the chick was given a poor prognosis, and the decision was made to euthanise. This case study highlights the nursing steps taken and the possible mitigations that could be applied in the future to improve outcomes. 相似文献
128.
Invasive aspergillosis (IA) is a major cause of morbidity and mortality in immunocompromised hosts. Economic expenditures prompted by this invasive fungal infection (IFI) are significant. Although, the duration and associated costs of hospitalization comprise the largest proportion of costs in large surveillance studies, the newer oral antifungal agents may impact significantly on these costs. A review of the pharmacoeconomic (PE) studies is provided focussing on primary therapy, salvage therapy, empiric therapy and prophylaxis for IA. PE evaluations have demonstrated the cost effectiveness and dominance of voriconazole for targeted primary treatment of IA compared with other available agents. Differences in the drug choice and analytic methodology of the PE analyses of empiric antifungal strategy hamper definitive conclusions about the agents employed as empiric antifungal that may be directed at suspected IA although both caspofungin and voriconazole appear to be cost effective and dominant over liposomal amphotericin B (LAmB), whereas LAmB is more costly than conventional amphotericin B. Posaconazole is the most cost‐effective agent for antifungal prophylaxis against IFI and IA. 相似文献
129.
Oral azole antifungal therapy is used extensively for all forms of aspergillosis, including allergic bronchopulmonary aspergillosis (ABPA). However, long-term therapy may increase the risk of resistance. Here we report itraconazole and voriconazole resistance with reduced susceptibility to posaconazole in Aspergillus fumigatus in two patients exposed to itraconazole. Patients were diagnosed with ABPA and Aspergillus bronchitis related to innate immune defects. An azole susceptible strain was initially isolated from patient 1, but later a genetically different azole-resistant strain was cultured, possibly related to sub-therapeutic itraconazole levels, which could be a trigger for selection of resistance. The mechanism of resistance identified in this case was an L98H change in Cyp51A, accompanied by a tandem repeat in the promoter region of cyp51A leading to increased expression. No cyp51A mutation was found in azole-resistant isolates recovered from patient 2. Both patients responded to posaconazole, with plasma levels of >1.0 mg/L. Subsequently, susceptible strains of different molecular types were cultured from both patients, suggesting eradication and replacement. 相似文献
130.
A Nosari P Oreste R Cairoli M Montillo G Carrafiello A Astolfi G Muti L Marbello A Tedeschi E Magliano E Morra 《American journal of hematology》2001,68(4):231-236
Sixty-one cases of Aspergillus infection (35 acute myeloid leukemia, 15 acute lymphoid leukemia, one myelodysplastic syndrome, two aplastic anemia, eight non-Hodgkin's lymphoma) seen in our department between January 1989 and July 1999 were studied retrospectively to evaluate the clinical characteristics, to ascertain the factors that influenced the outcome from mycotic infections, and whether early diagnosis and prolonged therapy permitted completion of scheduled intensive chemotherapy and bone marrow transplantation (BMT) without fungal recurrence. The patients were divided into three diagnostic categories: proven aspergillosis (autoptic or histologic diagnosis) n = 39, probable aspergillosis (radiological diagnosis with positive microbiology) n = 9, and possible aspergillosis (radiological diagnosis alone) n = 13. In the same period among 675 acute leukemia patients the incidence of proven or probable aspergillosis was 7.1%. At onset of infection 92% of patients were neutropenic (< 0.5 x 10(9)/L). The most frequent site of infection was the lung (90%); disseminated disease was present in 20 patients. Among 44 assessable patients, 12 (27%) failed to respond to early antifungal therapy and died. Thirty-two patients were cured with antifungal treatment, three of five nonneutropenic with only itraconazole, the others with amphotericin B 1 mg/Kg/day with or without itraconazole subsequently or with liposomal amphotericin, Ambisome, if renal toxicity occurred. Twenty-four of 29 neutropenic responders, all affected by acute leukemia, continued scheduled intensive chemotherapies. Pulmonary lobectomy was successfully combined with medical treatment in two cases before scheduled BMT. After infection nine patients were submitted to BMT (six allo, one marrow unrelated donor (MUD), two auto) with Ambisome or itraconazole as secondary prophylaxis without fungal relapse (follow-up: 25-99 months). The median time from fungal infection to transplant was five months, range 3-10. Thirteen of 29 surviving patients had leukemia relapse, but only three (23%) of these showed also fungal infection recurrence. In conclusion, a high index of suspicion and careful clinical and radiological examinations are the key to identifying infected patients early and to programming the following therapeutic steps. Above all in leukemia patients, prompt and aggressive administration of antifungal agents seems to improve the outcome of invasive fungal disease and to permit intensive chemotherapy completion and transplant. 相似文献